Panama will buy 4 million vaccines against covid-19 from Pfizer

In the image, the president of Panama, Laurentino Cortizo. EFE / Welcome Velasco / Archive

Panama, Nov 13 (EFE) .- The president of Panama, Laurentino Cortizo, announced this Friday that he approved 48 million dollars for the purchase of 4 million doses of the vaccine against covid-19 from Pfizer, which according to preliminary results It appears to prevent coronavirus infection by 90%.
Panama, a country of 4.2 million inhabitants, accumulates 144,477 confirmed infections and 2,856 deaths from COVID as of Friday, and has registered one of the highest transmission rates in the region.
“We have seen a light with the Pfizer vaccine, yesterday the cabinet council (ministers) approved 48 million dollars to buy 4 million vaccines,” said the president during a meeting with producers affected by the rains.
The Presidency of Panama published on its social networks that the Head of State “has authorized the acquisition of 4 million vaccines against SARS-COV2 from @pfizer. We won this battle together. #UnidosVenceremos.”
Cortizo explained that the 4 million vaccines will serve to immunize 2 million people, because each one must receive two doses.
The German consortium Biontech and the American Pfizer announced last Monday that they have ready the vaccine for COVID-19 that they have jointly developed and that they will request authorization for its widespread use from the US authorities next week.
According to Biontech, clinical studies carried out show that people who receive the vaccine have 90% greater protection against the coronavirus than those who are not vaccinated.
The BNT162b2 vaccine began development in January, phase 3 of the studies began in July, and so far 43,500 people have received at least one of the two injections that must be given within two weeks. Protection is obtained from the second injection.
Biotech and Pfizer estimate that this year they will be able to produce 50 million doses. For next year they have 1.3 billion doses.
Last September, the Government of Panama reported that it had approved a reserve of 20 million dollars for the purchase of a “safe and effective” vaccine against covid-19.
Panama participates in a phase 2 study to verify the clinical effectiveness of a vaccine from the German laboratory CureVac, for which more than 2,200 people have been considered as possible candidates for volunteers in the trial.
CureVac’s vaccine is part of the World Health Organization (WHO) COVAX initiative, designed to ensure equitable global access to covid-19 vaccines.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.